BioFire Joint Infection Panel REF: RFIT-ASY-0138 recalled over fire hazard
- Recall date
- April 22, 2026
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- BioFire Diagnostics, LLC recalls BioFire Joint Infection (JI) Panel REF: RFIT-ASY-0138, 30 test Kit.
- Recall number
- Z-2067-2026
- FDA classification
- Class II
- Brand / firm
- BioFire Diagnostics, LLC
- Sold / distributed
- Worldwide - US Nationwide distribution in the states of TX, NC, UT, MD and the countries of France, Italy, Germany, Spain, Belgium, Switzerland, United Kingdom, Netherlands, Poland, Austria, India, Finland, Czech Republic, Egypt, Lebanon, Morocco, Slovenia, Romania, Dominican Republic, Serbia.
Why it was recalled
Contamination to in-vitro diagnostic test may result in false positives.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
BioFire Joint Infection (JI) Panel REF: RFIT-ASY-0138, 30 test Kit.
Get recall alerts
Free email alert whenever BioFire Diagnostics, LLC has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: BioFire Diagnostics, LLC